gliclazide has been researched along with Reperfusion Injury in 2 studies
Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.
Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.
Excerpt | Relevance | Reference |
---|---|---|
"Gliclazide was administered intravenously into the right jugular vein for 12h simultaneously with the reperfusion." | 1.40 | Protective effect of treatment with low-dose gliclazide in a model of middle cerebral artery occlusion and reperfusion in rats. ( Li, H; Ma, M; Tan, F; Yu, Y, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tan, F | 1 |
Li, H | 1 |
Ma, M | 1 |
Yu, Y | 1 |
Bouskela, E | 1 |
Cyrino, FZ | 1 |
Conde, CM | 1 |
Garcia, AA | 1 |
2 other studies available for gliclazide and Reperfusion Injury
Article | Year |
---|---|
Protective effect of treatment with low-dose gliclazide in a model of middle cerebral artery occlusion and reperfusion in rats.
Topics: Animals; Apoptosis; Blood Glucose; Brain; Brain Ischemia; Disease Models, Animal; Gene Expression; G | 2014 |
Microvascular permeability with sulfonylureas in normal and diabetic hamsters.
Topics: Animals; Calcium Channel Blockers; Calcium Channels; Capillary Permeability; Cricetinae; Dextrans; D | 1997 |